S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TLIS Talis Biomedical Corporation

9.15

0.05 (0.55%)

04 May 2024 - Closed

Delayed by 15 minutes

Talis Biomedical initiated neutral at BofA despite a favorable view on Talis One

To read the full story on Seeking Alpha, click here.

Talis Biomedical (NASDAQ:TLIS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Talis Biomedical Charts.

Talis Biomedical (NASDAQ:TLIS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Talis Biomedical Charts.

Talis Biomedical Corporation News

Form 8-K - Current report
Saturday 27 January 2024 (3 months ago) • Edgar (US Regulatory)

Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash
Wednesday 15 November 2023 (6 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 2 September 2023 (8 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 11 August 2023 (9 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 11 August 2023 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 11 August 2023 (9 months ago) • Edgar (US Regulatory)

Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update
Friday 11 August 2023 (9 months ago) • GlobeNewswire Inc.

Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023
Thursday 3 August 2023 (9 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 2 August 2023 (9 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 2 August 2023 (9 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 2 August 2023 (9 months ago) • Edgar (US Regulatory)

Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)
Wednesday 2 August 2023 (9 months ago) • GlobeNewswire Inc.

More Talis Biomedical Corporation News Articles

Gold vs US Dollar

Woodside Petroleum

Australia And New Zealan...

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions